Rice Hall James & Associates’s OmniAb OABI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4M Buy
2,547,255
+146,167
+6% +$264K 0.22% 101
2025
Q4
$4.44M Sell
2,401,088
-10,950
-0.5% -$19K 0.24% 91
2025
Q3
$3.86M Sell
2,412,038
-215,085
-8% -$393K 0.21% 107
2025
Q2
$4.57M Buy
2,627,123
+46,343
+2% +$77.5K 0.25% 87
2025
Q1
$6.19M Sell
2,580,780
-68,227
-3% -$223K 0.36% 66
2024
Q4
$9.38M Sell
2,649,007
-73,314
-3% -$290K 0.52% 57
2024
Q3
$11.5M Buy
2,722,321
+163,038
+6% +$705K 0.62% 46
2024
Q2
$9.6M Sell
2,559,283
-81,258
-3% -$370K 0.58% 52
2024
Q1
$14.3M Sell
2,640,541
-72,103
-3% -$415K 0.82% 35
2023
Q4
$16.7M Sell
2,712,644
-68,182
-2% -$335K 0.97% 29
2023
Q3
$14.4M Sell
2,780,826
-51,550
-2% -$275K 0.92% 34
2023
Q2
$14.2M Buy
2,832,376
+12,274
+0.4% +$49.8K 0.81% 36
2023
Q1
$10.4M Buy
2,820,102
+336,336
+14% +$1.27M 0.59% 47
2022
Q4
$8.94M Buy
+2,483,766
New +$13M 0.51% 53

Other funds holding OABI

Rice Hall James & Associates's OABI Position: Q1 2026 in Review

Rice Hall James & Associates increased its OmniAb (OABI) stake by 6.1% in Q1 2026, buying an estimated $264K and bringing the position to 2,547,255 shares worth $4M. The position accounts for 0.22% of the portfolio, ranked #101.

Rice Hall James & Associates first reported a position in OABI in Q4 2022 and has held it in 14 quarters since. The position peaked at $16.7M in Q4 2023. 128 funds tracked by Wall St. Rank hold OABI as of Q1 2026.

  • Rice Hall James & Associates held 2,547,255 shares of OmniAb worth $4M as of Q1 2026.
  • Rice Hall James & Associates bought 146,167 OmniAb shares in Q1 2026, an estimated $264K.
  • OmniAb made up 0.22% of Rice Hall James & Associates's portfolio in Q1 2026, its #101 holding.
  • Rice Hall James & Associates first reported a position in OmniAb in Q4 2022 and has held it in 14 quarters since.
  • Rice Hall James & Associates's OmniAb position peaked at $16.7M in Q4 2023.
  • 128 funds tracked by Wall St. Rank held OmniAb as of Q1 2026.

Based on Rice Hall James & Associates's 13F filing for Q1 2026, filed 15 May 2026.